Domestic Violence Enhanced Perinatal Care Program in China

Launched by UNIVERSITY OF TEXAS AT AUSTIN · May 19, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new program designed to help pregnant women who have experienced intimate partner violence (IPV) in China. IPV is a serious issue that can impact the health of both mothers and their babies, and many pregnant women facing this problem have not received the support they need. This trial aims to create a structured support system within prenatal care that could be used in more clinics across the country, ultimately working to prevent violence and improve the health of mothers and infants.

To be eligible for this trial, participants need to be in the early stages of pregnancy (less than 13 weeks) and have experienced IPV either in the year before their pregnancy or during their current pregnancy. Unfortunately, women who cannot read and understand Chinese are not eligible to participate. Those who join the trial can expect to receive tailored support and resources aimed at addressing IPV during their prenatal visits, which could lead to better health outcomes for themselves and their babies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Being in early pregnancy (less than 13 weeks gestation) and screened positive for IPV in the year before pregnancy or during the current pregnancy.
• Exclusion Criteria:
• • Women who are not able to read and understand Chinese.